Staff

	Amy Efantis President & CEO
Global Initiatives
John Delacourt Chief Legal Officer and Vice President, Global Initiatives	Larisa Cervenakova Medical Director	George Schreiber Director Epidemiology
Brenna Raines Assistant Director Global Health Policy	Abigail Glaser Administrative Assistant
Source & International Affairs
Joshua Penrod Senior Vice President Source & International Affairs	Sonia Balboni Director Source & Standards	Alexa Wetzel Director Source Europe
Julia Fabens Assistant Director International Affairs	Brenda Norman Senior Manager Data	Diana Krueger Manager IQPP Audits
	Bobbi Stackman Coordinator Source & International Affairs
Regulatory & Quality Policy
Mary Gustafson Vice President Global Regulatory Policy	Dominika Misztela Senior Director Regulatory Policy Europe	Bill Speir Senior Director Advocacy and Regulatory Policy
Michelle Fransen Project Manager Health Initiatives	Michelle Mason Coordinator Global Regulatory Policy/ QSEAL Administrator
Public Affairs, Europe
Maarten Van Baelen Executive Director Europe	Karl Petrovsky Director Health Policy	Sándor Tóth Senior Manager Government Affairs and Health Policy
	Melanie Conrads Office Manager
Public Affairs, North America
Julie Birkofer Senior Vice President Public Affairs	Tom Lilburn Senior Director Government Relations	Mat Gulick Director Global Communications
Rachel Liebe Manager Global Communications	Tim Swope Manager Government Relations	Manisha Vasudeva Communications Specialist Global Communications
	April O'Neal Executive Assistant
Finance & Operations
Gene Stroshane Senior Director Finances & Operations	Cathy Izzi Senior Director Human Resources & Administrative Services	Mike McCormick Director IT & Facilities
	Charon Smith Senior Manager Accounts Receivables/Payables

PPTA News

PPTA Statement on FDA Guidance Documents +

PPTA is aware of the guidance documents released by the U.S. Food and Drug Administration on April 2 regarding Source plasma donor eligibility and is currently evaluating them. Our focus remains, as it has for nearly three decades, on patient and donor safety, and the safety of therapies derived from plasma.
Read More
PPTA Responds to The Guardian Article +

An article published March 25 by Stefanie Dodt and Samuel Gilbert in The Guardian continues the authors’ intentional maligning of plasma donors along the U.S.-Mexico border and perpetuates a divisive misrepresentation of the reality of border life between the United States and Mexico. The Plasma Protein Therapeutics Association (PPTA) and its member companies are grateful for every plasma donor, each of whom directly contributes to saving and improving the lives of people facing serious, inherited, and life-threatening diseases.
Read More
Letter to CMS to Allow Home Infusion COVID +

Dear Administrator Verma,

I am writing to ask for your consideration as the Centers for Medicare and Medicaid Services explores avenues to protect vulnerable patient populations during the COVID-19 pandemic. The Plasma Protein Therapeutics Association (PPTA) is the standard setting and global advocacy organization that represents plasma donation centers and manufacturers of plasma protein therapies. Our membership accounts for approximately 80% of plasma therapies in the United States. These therapies treat individuals with rare, chronic, and life-threatening conditions, such as immune deficiencies, certain neurological diseases, alpha-1 antitrypsin deficiency, and bleeding disorders.
Read More
New Coronavirus (SARS-CoV-2) and the Safety Margins of Plasma Protein Therapies +

The 2019 Novel Coronavirus (2019-noCoV), now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified by Chinese authorities in December 2019 in Wuhan province, China (1, 2). Infection with the virus is in most cases associated with an illness known as ‘COVID-19’, an abbreviation for ‘coronavirus disease 2019’ (3, 4).
Read More

1
2
3

› ‹

Mission Video

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Media and Information

Advocacy

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100

Terms of Use | Privacy Statement | Sitemap